bibliographicCitation |
Beissert T, Hundertmark A, Kaburova V, Travaglini L, Mian AA, Nervi C, Ruthardt M. Targeting of the N-terminal coiled coil oligomerization interface by a helix-2 peptide inhibits unmutated and imatinib-resistant BCR/ABL. Int J Cancer. 2008 Jun 15;122(12):2744–52. doi: 10.1002/ijc.23467. PMID: 18366061. |